Citation
81 FR 54817
Multiple canonical documents share this first-page citation.
- National Cancer Institute; Amended Notice of Meeting Wednesday, August 17, 2016 81 FR 54817
- National Cancer Institute; Amended Notice of Meeting Wednesday, August 17, 2016 81 FR 54817
- National Heart, Lung, and Blood Institute; Notice of Meeting Wednesday, August 17, 2016 81 FR 54816
- National Heart, Lung, and Blood Institute; Notice of Meeting Wednesday, August 17, 2016 81 FR 54816
- National Institute on Aging; Notice of Closed Meeting Wednesday, August 17, 2016 81 FR 54817
- National Institute on Aging; Notice of Closed Meeting Wednesday, August 17, 2016 81 FR 54817
- Prospective Grant of Exclusive Patent License: Development of T Cell Receptors (TCRs) Targeting the KRAS G12D Mutation for the Treatment of Cancer Wednesday, August 17, 2016 81 FR 54817
- Prospective Grant of Exclusive Patent License: Development of T Cell Receptors (TCRs) Targeting the KRAS G12D Mutation for the Treatment of Cancer Wednesday, August 17, 2016 81 FR 54817
- Federal Register Vol. 81, No.159, August 17, 2016 Wednesday, August 17, 2016 81 FR 54817